Cargando…

Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand

Detalles Bibliográficos
Autores principales: Deerochanawong, Chaicharn, Krittayaphong, Rungroj, Romano, Jack Garcia Uranga, Rhee, Nicolai A., Permsuwan, Unchalee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126194/
https://www.ncbi.nlm.nih.gov/pubmed/37000391
http://dx.doi.org/10.1007/s13300-023-01392-7
_version_ 1785030185257533440
author Deerochanawong, Chaicharn
Krittayaphong, Rungroj
Romano, Jack Garcia Uranga
Rhee, Nicolai A.
Permsuwan, Unchalee
author_facet Deerochanawong, Chaicharn
Krittayaphong, Rungroj
Romano, Jack Garcia Uranga
Rhee, Nicolai A.
Permsuwan, Unchalee
author_sort Deerochanawong, Chaicharn
collection PubMed
description
format Online
Article
Text
id pubmed-10126194
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-101261942023-04-26 Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand Deerochanawong, Chaicharn Krittayaphong, Rungroj Romano, Jack Garcia Uranga Rhee, Nicolai A. Permsuwan, Unchalee Diabetes Ther Author Correction Springer Healthcare 2023-03-31 2023-05 /pmc/articles/PMC10126194/ /pubmed/37000391 http://dx.doi.org/10.1007/s13300-023-01392-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Author Correction
Deerochanawong, Chaicharn
Krittayaphong, Rungroj
Romano, Jack Garcia Uranga
Rhee, Nicolai A.
Permsuwan, Unchalee
Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
title Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
title_full Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
title_fullStr Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
title_full_unstemmed Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
title_short Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
title_sort correction to: cost–utility of liraglutide plus standard of care versus standard of care in people with type 2 diabetes and cardiovascular risk in thailand
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126194/
https://www.ncbi.nlm.nih.gov/pubmed/37000391
http://dx.doi.org/10.1007/s13300-023-01392-7
work_keys_str_mv AT deerochanawongchaicharn correctiontocostutilityofliraglutideplusstandardofcareversusstandardofcareinpeoplewithtype2diabetesandcardiovascularriskinthailand
AT krittayaphongrungroj correctiontocostutilityofliraglutideplusstandardofcareversusstandardofcareinpeoplewithtype2diabetesandcardiovascularriskinthailand
AT romanojackgarciauranga correctiontocostutilityofliraglutideplusstandardofcareversusstandardofcareinpeoplewithtype2diabetesandcardiovascularriskinthailand
AT rheenicolaia correctiontocostutilityofliraglutideplusstandardofcareversusstandardofcareinpeoplewithtype2diabetesandcardiovascularriskinthailand
AT permsuwanunchalee correctiontocostutilityofliraglutideplusstandardofcareversusstandardofcareinpeoplewithtype2diabetesandcardiovascularriskinthailand